Literature DB >> 25864914

Overview of the special issue on HBV immunity.

Antonio Bertoletti1, Fu-Sheng Wang2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25864914      PMCID： PMC4654325          DOI： 10.1038/cmi.2015.24

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN： 1672-7681            Impact factor:   11.530


× No keyword cloud information.
  11 in total

Review 1.  Role of interleukin-21 in HBV infection: friend or foe?

Authors:  Yongyin Li; Libo Tang; Jinlin Hou
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

Review 2.  Dissecting the dendritic cell controversy in chronic hepatitis B virus infection.

Authors:  Adam J Gehring; June Ann D'Angelo
Journal:  Cell Mol Immunol       Date:  2014-11-03       Impact factor: 11.530

3.  The genome of a Mesozoic paleovirus reveals the evolution of hepatitis B viruses.

Authors:  Alexander Suh; Jürgen Brosius; Jürgen Schmitz; Jan Ole Kriegs
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

Review 4.  Innate and adaptive immune responses in chronic hepatitis B virus infections: towards restoration of immune control of viral infection.

Authors:  Antonio Bertoletti; Carlo Ferrari
Journal:  Gut       Date:  2011-12-09       Impact factor: 23.059

Review 5.  Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.

Authors:  Zhiyong Ma; Ejuan Zhang; Dongliang Yang; Mengji Lu
Journal:  Cell Mol Immunol       Date:  2014-11-24       Impact factor: 11.530

Review 6.  Chronic hepatitis B: role of anti-platelet therapy in inflammation control.

Authors:  Roberto Aiolfi; Giovanni Sitia
Journal:  Cell Mol Immunol       Date:  2015-01-12       Impact factor: 11.530

7.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

Review 8.  The immune tolerant phase of chronic HBV infection: new perspectives on an old concept.

Authors:  Antonio Bertoletti; Patrick T Kennedy
Journal:  Cell Mol Immunol       Date:  2014-09-01       Impact factor: 11.530

9.  Dating the origin and dispersal of hepatitis B virus infection in humans and primates.

Authors:  Dimitrios Paraskevis; Gkikas Magiorkinis; Emmanouil Magiorkinis; Simon Y W Ho; Robert Belshaw; Jean-Pierre Allain; Angelos Hatzakis
Journal:  Hepatology       Date:  2013-02-07       Impact factor: 17.425

Review 10.  NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma.

Authors:  Cheng Sun; Haoyu Sun; Cai Zhang; Zhigang Tian
Journal:  Cell Mol Immunol       Date:  2014-10-13       Impact factor: 11.530
View more
  4 in total

1.  New horizon for radical cure of chronic hepatitis B virus infection.

Authors:  Kazuto Tajiri; Yukihiro Shimizu
Journal:  World J Hepatol       Date:  2016-07-28

Review 2.  Natural killer cells in liver diseases.

Authors:  Meijuan Zheng; Haoyu Sun; Zhigang Tian
Journal:  Front Med       Date:  2018-04-19       Impact factor: 4.592

3.  An Immuno-Clinic score model for evaluating T cell immunity and predicting early antiviral therapy effectiveness in chronic hepatitis B.

Authors:  Yurong Gu; Xiaoyan Li; Lin Gu; Yifan Lian; Ke Wang; Youming Chen; Jing Lai; Yongyu Mei; Jing Liu; Zexuan Huang; Min Zhang; Lubiao Chen; Yuehua Huang
Journal:  Aging (Albany NY)       Date:  2020-12-26       Impact factor: 5.682

4.  Restoration of HBV-specific CD8+ T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy.

Authors:  Dongyao Wang; Binqing Fu; Xiaokun Shen; Chuang Guo; Yanyan Liu; Junfei Zhang; Rui Sun; Ying Ye; Jiabin Li; Zhigang Tian; Haiming Wei
Journal:  Signal Transduct Target Ther       Date:  2021-11-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.